On Stockhead today, Guy Le Page on where the Germans went wrong, GS cranks up its oil price forecast, and how the Russian invasion hits lithium supplies.

But first … the day ahead.

Local shares are set to open higher today. At 8am AEDT, the ASX 200 March futures is pointing up by 0.42%.



The following companies went into trading halts yesterday and are expected out in the next few days:

Sezzle (ASX:SZL)– takeover offer from Zip Co

Blue Star Helium (ASX:BNL) – ahead of a drilling update

Roto Gro International (ASX:RGI ) – become aware of material uncertainty in financial position


MARKETS (updated at 8am AEDT)

Gold: $US1,909.33 (+1.16%)

Silver: $US24.47 (+1.15%)

Oil (WTI): $US95.77 (+4.50%)

Oil (Brent): $US100.90 (+3.03%)

Coal: $US275.00 (+15.00%)

Aust Coking Coal (steelmaking): $445.0/t (-0.3%)

Newcastle Coal (thermal): $197/t (0.00%)

Iron 62pc Fe: $US141.76 (-0.63%)

AUD/USD: $US0.7263 (+0.51%)

Bitcoin: $US41,800 (+10.35%)



Wiluna Mining (ASX:WMC) shipped its first gold concentrate.

To keep up to date with Stockhead coverage, follow our Twitter page or sign up to our members-only Facebook group here.

For all you crypto lovers Stockhead’s Coinhead Facebook group is the place to share your views, insights, tips and ideas.

Also, be sure to check in at 10.20am each day for our daily ‘10 at 10’ column — a live summary of winners & losers at the opening bell.



(Stocks highlighted in yellow rose after making announcements during the trading day).

Scroll or swipe to reveal table. Click headings to sort.

Monday’s Charlie Sheen winners:

Lakes Blue Energy (ASX:LKO)

CardieX (ASX:CDX)

Grange Resources (ASX:GRR)

Lodestar Minerals (ASX:LSR)

All higher on no news.

Brazil’s health regulatory agency, ANVISA, has granted market authorisation for Lumos Diagnostics'(ASX:LDX)FebriDx –  rapid 10-minute point-of-care test to aid in detecting and differentiating bacterial from viral acute respiratory infections. The approval means that FebriDx is now available to healthcare providers in the UK, Europe, Canada, Australia, UAE and Brazil.

Another leader on Monday is the vitamins company Biome Australia (ASX:BIO) which reported record sales for the half.

Revenue all but doubled, to $1.8m on pcp, while the operating loss for the period was $1.98m, a 40% reduction compared to the pcp. Biome says its outlook is positive, with revenue growth expected to continue, and two new product launches planned in the second half. Shares have gained 6%.



(Stocks highlighted in yellow rose after making announcements during the trading day).

Scroll or swipe to reveal table. Click headings to sort.

Comparisons website iSelect (ASX:ISU) has acquired a 49% stake in rival CIMET for $26 million. The company announced the two-stage put and call options with CIMET, an end-to-end digital comparison platform, which wants to take energy comparison overseas and get a BNPL comparison going.

ISU will additionally acquire a 49% share in Indian company VConnex, which provides technology and other services to CIMET.

Meanwhile, the company turned first half NPAT around, making a $500k profit, compared with -$3.6m last year, while underlying EBITDA was $6.6m for H1 FY22, down from $13.2m.